Feasibility study of target capture RNA-sequencing for B-cell acute lymphoblastic leukemia
Not Applicable
Recruiting
- Conditions
- B-cell Acute Lymphoblastic Lekaemia
- Registration Number
- JPRN-UMIN000038710
- Lead Sponsor
- agoya Medical Center
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 115
Inclusion Criteria
Not provided
Exclusion Criteria
Inappropriate patients judged by principal investigator or co-investigator
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Frequency of subtype detection by target capture RNA-sequencing within 60 days
- Secondary Outcome Measures
Name Time Method Frequency of subtype detection by cytogenetic testing Evaluating the time period to returning a report Consistency with the results of clinical examination (RT-PCR or FISH) Consistency with the results of other methods (RNA-seq, whole genome sequencing, target capture DNA-seq, RT-PCR) Evaluating costs of target capture RNA-seq in clinical settings Frequency of the patients who received allogeneic transplantation Frequency of the patients who received tyrosine kinase inhibitor